Get startedLog in
    Picture of Sprint Bioscience AB logo

    SPRINT — Sprint Bioscience AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSuper Stock
    All News

    Brief: Sprint Bioscience: Positive Preclinical Result In Oncology Program Targeting TREX1

    Picture of Sprint Bioscience AB logoSprint Bioscience AB
    11/04/2024 14:35
    April 11 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * POSITIVE PRECLINICAL RESULTS IN SPRINT BIOSCIENCE'S
ONCOLOGY
PROGRAM TARGETING TREX1
    * RESULTS SHOW TREATMENT WITH TREX1 INHIBITORS RESULTS IN
IMPROVED
IMMUNE RESPONSE, INHIBITED TUMOR GROWTH

Source text for Eikon:  ID:nMFNbJsStn 
Further company coverage:  SPRINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Sprint Bioscience AB

    See all news